Trading Summary - January 25. Some upward movement today

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
233
Trading Summary - January 25.

Some upward movement today on another satisfactory status quo day for $SFLM in the same bottom range - less than 25% of target price .02+ range (ie anything under .0052) - despite the fact that most OTC market top traders needed to concentrate on the $ENZC video conference and subsequent move up also.

Walked down asks in the .0016 > .0019 range were taken out - with ask buys up to 1.75M - and the .0020s were up until a couple of mickey mouse undercut asks were put at .0019 during the $ENZC conference.

None of the asks are of any significance to hinder a quick break above .0030 towards the .01 > .02 range needed for OTCQB uplisting - and as appropriate to its $10.241M revenue market cap - whenever the top traders of $SFLM decide to concentrate on it.

As shown in the report for December 31, 2021, the vast majority of shares are held with a cost basis under .0052 now with the balance above held by longs who didn't sell for a tax loss as it is self-evident the price should be going above .02 at some point in 2022.

Overall, 7.8M shares were bought today - almost all at .0018 > .0019 compared to .0016 > .0017 over the past few days.

New interest traders / alerters + long-term traders with significant followings as at January 23 numbered at least 165 - list here:

https://investorshangout.com/post/view?id=6326555

Particular points they like are:

- Real revenue of $10.241M in 2021.

- Revenue growth of 34.75% in 2021 - beating the target of 30%.

- Operating profit achieved in Q3.

- $49K in cash available for inventory purchases at end-Q3.

- Assets of $1.398M at end-Q3.

- Low Unrestricted O/S of 837M - with none added in the last 3+ months.

- How thin it is into the .01 > .02 range.

- Multiple catalysts ahead throughout 2022.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO. Trading some on every surge allows a larger core to be held on a cost basis that is essentially "free" - already paid for by banked profits.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .063 > .1100 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0020 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .063 > .1100.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150, $15K profit at .02, $57K profit at .074 or $102.5K profit at .1075.

All that matters is who got where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead in 2022.

Latest DD - updated January 23 - here:

https://investorshangout.com/post/view?id=6326574

$SFLM was the #1 Top Profit Pick and #1 Top Banked Profit stock of 2021 on my Watch List.

It is the joint #1 Top Profit Pick for the whole of 2022 (with $ENZC).

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

iHub has been deliberated marginalized due to time-wasting nonsense there with all serious interest successfully directed to here over the last several months - with typically 500 > 700+ views per day - and repeated where interest in "real" companies is known to exist.

Watch for the next PR which I would expect to cover the excellent Q3 results, the sales since in Q4, acquistions of collectibles companies and expansion of the NFT Division with artists recruited Nationwide.

The Share Structure was updated after the close on January 20 - again showing no change and confirming no dilution for 3+ months - with the Unrestricted O/S remaining at a low 837M.

The next auction is this Thursday evening - expect another $200K+ week.

Advance sales ahead of the auction at "Buy It Now" prices are already $15,061 - including one for $8,998 - again proving that revenue is only limited by inventory available with high-value, desirable items going immediately.

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 0

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 4

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 3

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 2

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 1

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 3

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 0

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 0

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Freight Technologies Marks Successful Regrowth on Nasdaq

Updated Category News Views 40

Freight Technologies Achieves Nasdaq Compliance Freight Technologies, Inc. (Nasdaq: FRGT), also known as Fr8Tech, has recently made headlines by successfully regaining compliance with the Nasdaq Stock Market. On October 9, 2024, the Company received official confirmation from Nasdaq’s Listing Qualifications Staff that it meets the necessary minimum bid price...

Continue Reading
Tech Rally: Cadence Soars While Crude Prices Spike on Tensions

Updated Category News Views 230

So here’s the scoop: tech stocks jumped hard on Wednesday, with the Nasdaq 100 flying up 1.4% past 25,000. That kind of move? It's a solid rebound after some serious bruising in the sector lately. The S&P tagged along with a respectable 1% gain while the Dow trailed at a meager 0.7%. This isn’t just noise; it signals a potential shift in market sentiment that traders...

Continue Reading
Texas Housing Market Trends: Prices Steady Amid Listings Spike

Updated Category News Views 249

Texas Housing Market Update According to the latest housing report, statewide listings in Texas have surged by 30.4%. This increase highlights a significant activity shift in the market, as noted in the recent Texas Quarterly Housing Report from Texas REALTORS. Sales Price Trends Across Metros In the third quarter, median home sales prices reflected a fluctuating...

Continue Reading
Nasus Pharma's IPO: Paving the Way for Innovative Treatments

Updated Category News Views 169

Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...

Continue Reading
LightPath Technologies Secures BlackDiamond Glass Contract Growth

Updated Category News Views 74

LightPath Technologies Expands in the European Defense Market LightPath Technologies, Inc. (NASDAQ: LPTH) is making significant strides in the field of optics and imaging systems for both defense and commercial applications. The company recently announced an initial development contract from a European defense customer, marking a pivotal moment in its operations. The...

Continue Reading